Blend Labs CFO’s Rule 10b5‑1 Sale Highlights Insider Caution Amid Sharply Declining Stock Price
Blend Labs insider Oxana Tkach sells 5,625 shares at $1.59, reflecting cautious portfolio moves amid a steep stock decline and mixed executive activity.
3 minutes to read

